Metraipolis › archive › dc_ef83015f7c61

The impact of metabolic syndrome on survival outcomes in urothelial carcinoma: a retrospective cohort study — Europe PMC PMID:42453892

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42453892
DOI
10.3389/fonc.2026.1858817
License (as archived)
solo-consultazione
Archived
2026-10-18T14:47:56.237Z
SHA-256 of the archived text
ea7d3c694267908e94ece1fbd30304145b3452dfccd1040aada627927e4be16f
Stable URL of this page
https://metraipolis.com/documento/dc_ef83015f7c61

How to cite

The impact of metabolic syndrome on survival outcomes in urothelial carcinoma: a retrospective cohort study — Europe PMC PMID:42453892 — Europe PMC (en), https://europepmc.org/article/MED/42453892 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ef83015f7c61 (Metraipolis archive dc_ef83015f7c61, sha256 ea7d3c694267908e94ece1fbd30304145b3452dfccd1040aada627927e4be16f)
BibTeX
@misc{dcef83015f7c61,
  title = {The impact of metabolic syndrome on survival outcomes in urothelial carcinoma: a retrospective cohort study — Europe PMC PMID:42453892},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42453892},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ef83015f7c61; sha256 ea7d3c694267908e94ece1fbd30304145b3452dfccd1040aada627927e4be16f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42453892. Agents can read the archived copy with the MCP tool read_document.